Cite
HARVARD Citation
Picard, F. et al. (2021). Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry. International journal of cardiology. pp. 96-104. [Online].